Vivo Opportunity, LLC

10% OwnerInMed Pharmaceuticals Inc. (INM) · full profile →Form 4 · filed Jun 11, 2026
Net Buying
Open-Market Buys
$392K
Open-Market Sells
$0
Net Open-Market Flow
$392K
Transactions
18
18 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2026Buy(P)30K$1.52$45K718K
Jun 8, 2026Buy(P)3K$1.52$5K73K
Jun 5, 2026Buy(P)50K$1.57$78K689K
Jun 5, 2026Buy(P)5K$1.57$8K70K
Jun 4, 2026Buy(P)618$1.57$97065K
Jun 4, 2026Buy(P)6K$1.57$10K639K
Jun 3, 2026Buy(P)7K$1.55$11K633K
Jun 3, 2026Buy(P)714$1.55$1K64K
Jun 2, 2026Buy(P)2K$1.52$3K63K
Jun 2, 2026Buy(P)21K$1.52$32K626K
Jun 1, 2026Buy(P)1K$1.55$2K61K
Jun 1, 2026Buy(P)15K$1.55$23K605K
May 29, 2026Buy(P)2K$1.57$3K60K
May 29, 2026Buy(P)16K$1.57$25K590K
May 21, 2026Buy(P)31K$1.69$52K574K
May 21, 2026Buy(P)3K$1.69$5K58K
May 20, 2026Buy(P)5K$1.56$8K55K
May 20, 2026Buy(P)51K$1.56$80K543K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-067505) within minutes of acceptance. Every field above traces to the original document. Verify it directly: